NanoVibronix (NAOV) delays filing of Q2 2025 Form 10-Q

Rhea-AI Filing Summary

NanoVibronix, Inc. filed a notification that it will be late in submitting its Quarterly Report on Form 10-Q for the period ended June 30, 2025. The company states it cannot file the report within the prescribed time without unreasonable effort and expense.

NanoVibronix explains that it needs additional time to prepare, compile and analyze supporting documentation and to complete its disclosures and financial statement preparation and review process. The company anticipates filing the Form 10-Q no later than the fifth calendar day following the prescribed filing date.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One):	☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR
	For Period Ended: June 30, 2025
	☐ Transition Report on Form 10-K
	☐ Transition Report on Form 20-F
	☐ Transition Report on Form 11-K
	☐ Transition Report on Form 10-Q
	For the Transition Period Ended: ________________________

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

NanoVibronix, Inc.

Full name of Registrant

Former Name if Applicable

969 Pruitt Place

Address of Principal Executive Office (Street and Number)

Tyler TX 75703

City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

☒		(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
		(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
		(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

NanoVibronix, Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “Form 10-Q”), within the prescribed time period. Additional time is needed for the Company to prepare, compile and analyze supporting documentation in order to complete its disclosures and financial statement preparation and review process to finalize the Form 10-Q. The Company anticipates that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Doron Besser, M.D.		(914) 233-3004
(Name)		(Area Code) (Telephone Number)

	(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No
	(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

NanoVibronix, Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date	August 14, 2025		By:	/s/ Doron Besser, M.D.
			Name:	Doron Besser, M.D.
			Title:	Chief Executive Officer

FAQ

Why did NanoVibronix (NAOV) file an NT 10-Q for the June 30, 2025 quarter?

NanoVibronix filed an NT 10-Q because it will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 within the prescribed time period.

What reason does NanoVibronix (NAOV) give for delaying its Q2 2025 Form 10-Q?

The company states it needs additional time to prepare, compile and analyze supporting documentation in order to complete its disclosures and financial statement preparation and review process for the Form 10-Q.

When does NanoVibronix expect to file the delayed Q2 2025 Form 10-Q?

NanoVibronix anticipates that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.

Which filing is affected by NanoVibronix's NT 10-Q notice?

The notice relates to NanoVibronix, Inc.'s Quarterly Report on Form 10-Q for the period ended June 30, 2025.

Who signed NanoVibronix's NT 10-Q for the June 30, 2025 period?

The notification was signed on behalf of NanoVibronix, Inc. by Doron Besser, M.D., the company’s Chief Executive Officer.

Does NanoVibronix indicate that preparing the Q2 2025 Form 10-Q would require unreasonable effort or expense by the deadline?

Yes. NanoVibronix states that it will not, without unreasonable effort and expense, be able to file its Form 10-Q for the period ended June 30, 2025 within the prescribed time period.